How Does Denali Therapeutics Inc (DNLI) Stock Stack Up in the Healthcare Sector?

Monday, January 27, 2020 12:24 PM | InvestorsObserver Analysts

The 60 rating InvestorsObserver gives to Denali Therapeutics Inc (DNLI) stock puts it near the top of the Healthcare sector.

In addition to scoring higher than 77 percent of stocks in the Healthcare sector, DNLI’s 60 overall rating means the stock scores better than 60 of all stocks.

Click Here to get the full Stock Score Report on Denali Therapeutics Inc (DNLI) Stock.

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style.

Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Denali Therapeutics Inc Stock Today?

Denali Therapeutics Inc (DNLI) stock is up 12.49% while the S&P 500 is lower by -1.21% as of 12:22 PM on Monday, Jan 27. DNLI has gained $3.08 from the previous closing price of $24.65 on volume of 577,084 shares. Over the past year the S&P 500 is higher by 23.13% while DNLI has gained 29.76%. DNLI lost -$0.68 per share the over the last 12 months.

To see the top 5 stocks in Healthcare click here.

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium

InvestorsObserver Premium

$ 16.58 $ 8.29 /month
$199 $99.50 billed annually

Related Articles

Sector Update: Health Care

Sector Update: Health Care Stocks Falling as Market Rout Continues

Sector Update: Chipmakers Carrying Tech Stocks to Small Gains

Related Companies